Letters to the Editor

Efficacy and safety of apremilast in a patient with paraneoplastic dermatomyositis with resistant skin disease

N. Cabas¹, M. Turina², S. Pizzolitto³, S. De Vita⁴, L. Quartuccio⁵

Division of Rheumatology, Department of Medicine, University of Udine, ASUFC, Udine, Italy.
Unit of Pathology, Santa Maria della Misericordia Academic Medical Centre, Udine, Italy.
Unit of Pathology, Santa Maria della Misericordia Academic Medical Centre, Udine, Italy.
Division of Rheumatology, Department of Medicine, University of Udine, ASUFC, Udine, Italy.
Division of Rheumatology, Department of Medicine, University of Udine, ASUFC, Udine, Italy. luca.quartuccio@uniud.it

CER16206
2023 Vol.41, N°2
PI 0396, PF 0397
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 36861740 [PubMed]

Received: 10/09/2022
Accepted : 11/11/2022
In Press: 02/03/2023
Published: 02/03/2023